Rabelent Injection
Marketer
Digilent Pharmaceuticals Private Limited
Salt Composition
Rabeprazole (20mg)
Overview Rabelent Injection
AcidGard Injection reduces stomach acid production. It treats acid-related gastrointestinal disorders including reflux, indigestion, peptic ulcers, and other conditions stemming from excessive acidity. AcidGard Injection offers rapid relief from heartburn and similar symptoms. It also prevents stress ulcers in critically ill patients and is administered pre-anesthesia to mitigate aspiration risks. Classified as a proton pump inhibitor (PPI), it's intravenously administered by a healthcare professional only when deemed superior to oral medication. Dosage depends on your condition and response; treatment duration is determined by your physician. Continue taking it as prescribed, even with symptom improvement. Smaller, more frequent meals and avoiding caffeine, spicy, and fatty foods enhance treatment efficacy. Common side effects, usually mild, include nausea, vomiting, headache, dizziness, gas, diarrhea, abdominal pain, and thrombophlebitis (vein inflammation). Persistent or bothersome side effects warrant medical attention. Prolonged use (over a year) may elevate fracture risk, particularly at higher doses. Discuss bone loss prevention strategies, such as calcium and vitamin D supplementation, with your doctor. Hypomagnesemia (low magnesium) can occur after three months or more of use, potentially causing fatigue, confusion, dizziness, muscle spasms, and arrhythmia. Your doctor may monitor your magnesium levels. AcidGard Injection is contraindicated for individuals with severe liver disease, those on HIV medications, those with prior allergic reactions to similar drugs, or those with osteoporosis. Pregnant or breastfeeding individuals should consult their physician. Alcohol should be avoided due to its acid-stimulating effects. Refrain from operating machinery if dizziness or drowsiness occurs.
Primary Ingredients of Rabelent Injection
No text provided to rephrase.
Uses of Rabelent Injection
Managing acid reflux and peptic ulcers.
Major Benefits of Rabelent Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Rabelent Injection:
- Nausea
- Vomiting
- Headache
- Dizziness
- Flatulence
- Diarrhea
- Stomach pain
- Thrombophlebitis
How to use Rabelent Injection:
Administering this medication will be handled by your physician or their qualified nurse; self-medication is strictly prohibited.
How Rabelent Injection works:
Gastric acid production is suppressed by Rabelent Injection, a proton pump inhibitor, thus alleviating heartburn and acid indigestion symptoms.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Rabelent Injection concurrently with alcohol. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
The use of Rabelent Injection during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Administering Rabelent Injection while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Rabelent Injection on driving ability is undetermined. Refrain from driving if you exhibit any symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Rabelent Injection poses no safety concerns for patients with renal impairment; dosage modification is unnecessary.
LiverCAUTION
Exercise caution when administering Rabelent Injection to individuals with advanced hepatic impairment; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Rabelent Injection :
Omit a dose of Rabelent Injection? Seek your physician's advice.
Facts to Know About Rabelent Injection
| Label | Value |
|---|---|
| Chemical Type | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Actions | Gastric acid suppressants |


